Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).

Brad S. Kahl, MD, Michael E. Williams, MD, Fangxin Hong, Ph.D, Randy Gascoyne, MD, Sandra J. Horning, MD

Blood (2007) 110 (11): 3420.

https://doi.org/10.1182/blood.V110.11.3420.3420

Published: 2007

Journal Articles

Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.

Mukesh Chhanabhai, FRCPC, Joseph Connors, MD, Wayne Seville, MD, Dan Matso, PhD, Randy Gascoyne, MD

Blood (2006) 108 (11): 2031.

https://doi.org/10.1182/blood.V108.11.2031.2031

Published: 2006

Journal Articles

BCL11A XL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.

Karen Pulford, PhD, Alison H. Banham, DPhil, Linden Lyne, DPhil, Margaret Jones, BSc, Greg Ippolito, PhD, Hiu Liu, BSc, Phil W. Tucker, PhD, Giovanna Roncador, PhD, Elena Lucas, BSc, Sally Ashe, PhD, Elizabeth Stockwin, PhD, Renata Walewska, PhD, Elisabeth L. Karran, PhD, Randy Gascoyne, MD, David Y. Mason, MD, Martin J.S. Dyer, FRCPath

Blood (2005) 106 (11): 4392.

https://doi.org/10.1182/blood.V106.11.4392.4392

Published: 2005

Journal Articles

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Bruce D. Cheson, MD, Beate Pfistner, PhD, Malik E. Juweid, MD, Lena Specht, MD, PhD, Steven T. Rosen, MD, Randy Gascoyne, MD, Sigrid Stroobants, MD, PhD, Volker Diehl, MD

Blood (2005) 106 (11): 18.

https://doi.org/10.1182/blood.V106.11.18.18

Published: 2005

Journal Articles

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Blood (2004) 104 (11): 415.

https://doi.org/10.1182/blood.V104.11.415.415

Published: 2004

NARROW

Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).

Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.

BCL11A XL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Email alerts

ASH Publications

American Society of Hematology

Preliminary Pharmacokinetic (PK) Analysis of Eastern Cooperative Oncology Group Protocol E4402: Rituximab Extended Schedule or Re-Treatment Trial (RESORT).

Bone Marow (BM) Involvement in Diffuse Large B Cell Lymphoma (DLBCL): Clinical Impact of Discordant Disease.

BCL11A XL Protein: Its Distribution in Normal and Malignant Tissues and Use as a Marker for Plasmacytoid Dendritic Cells.

Revised Response Criteria for Malignant Lymphomas From the Members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma, Represented by:.

Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only